Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Capecitabine and oxaliplatin combined with pembrolizumab are a tolerable and potentially effective treatment for advanced refractory BTC.
Monge et al. 2022 The Oncologist 27: e273-e285
Treatment was well-tolerated, and the most common treatment-related grade 3 or 4 adverse events were lymphocytopenia, anemia, and decreased platelet count. [Monge et al. 2022 The Oncologist 27: e273-e285](brain://ld…